Events Search and Views Navigation

Event Views Navigation

Today

Latest Past Events

MedTech Strategist Innovation Summit San Francisco 2022

Innovation Summit San Francisco is MedTech’s must-attend investing and partnering conference, bringing together the greatest minds in the global medical device industry. UCLA Biodesign is excited to participate in this conference through the panel: "Driving Innovation by Improving Regulatory and Reimbursement: It's All About the Data" • Josh Makower, Director and Co-Founder, Stanford Byers Center for Biodesign • Jennifer McCaney, Executive Director, UCLA Biodesign • Stephen Levin, Editor-in-Chief, Market Pathways (moderator) Learn more about Innovation Summit SF and apply to present, attend, and more here: bit.ly/3ynVzGA.

Featured Featured

UCLA Biodesign’s 2nd Annual Women in Healthtech Leadership Lecture

Join Lisa Wipperman Heine for a conversation about her career journey and lessons learned across a cadre of roles at venture-backed startups to large, multinational companies to leading her first startup as CEO through to acquisition in less than four years. Lisa Wipperman Heine has served in the Medtech industry for over 30 years holding leadership roles in both large Medtech companies as well as venture-backed start-ups. She currently serves on the Board of Directors for 3 public medtech/biotech companies as well as 1 early-stage private company. Recently, Lisa was also President and Chief Executive Officer at preCARDIA, Inc., an early stage, heart failure focused medtech company which was acquired by Abiomed, Inc. in 2021. Ms. Heine also [...]

UCLA Biodesign Innovation Showcase & Graduation

Join UCLA Biodesign in celebrating the graduation of the 2021-2022 Biodesign Fellows. The session will showcase pitches from the UCLA Biodesign Fellows and a keynote address by Dr. Nick West, Chief Medical Officer and Divisional Vice President of Global Medical Affairs of Abbott Vascular. The program will feature innovative product solutions spanning digital health, diagnostics, interventional devices, and technology-enabled health services, as well as opening remarks by Johnese Spisso, President of UCLA Health and CEO of UCLA Hospitals and Clinics, Dr. Steve Dubinett, Interim Dean of the David Geffen School of Medicine at UCLA and Antonio Bernardo, Dean of the UCLA Anderson School of Management. Members of the UCLA community and the public are welcome to join in [...]

Go to Top